You are viewing the site in preview mode
Skip to main content
|
Items
|
All
|
NF group
|
n
|
Control group
|
n
|
p
|
|---|
|
Number of patient
|
54
|
28
|
28
|
26
|
26
| |
|
Sex (male/female)
|
36/18
|
17/11
|
28
|
19/7
|
26
|
n.s.a
|
|
Age (years)
|
76.4 ± 5.0 (70.0–87.0)
|
77.1 ± 4.8 (70.0–87.0)
|
28
|
75.6 ± 5.0 (70.0–87.0)
|
26
|
n.s.b
|
|
Dialysis vintage (years)
|
8.3 ± 6.2 (0.5–30.0)
|
9.8 ± 7.4 (0.5–30.0)
|
28
|
6.8 ± 4.2 (1.0–15.0)
|
26
|
n.s.c
|
|
Dry weight (kg)
|
52.5 ± 9.8 (33.8–90.0)
|
50.8 ± 8.8 (33.8–67.8)
|
28
|
54.3 ± 10.6 (34.5–90.0)
|
26
|
n.s. b
|
|
Albumin concentration before dialysis (g/dL)
|
3.6 ± 0.3 (3.0–4.4)
|
3.6 ± 0.3 (3.1–4.0)
|
27
|
3.6 ± 0.3 (3.0–4.4)
|
25
|
n.s. b
|
|
Dialysis condition
|
|
Blood flow rate (mL/min)
|
219.3 ± 30.3 (150–300)
|
218.9 ± 32.7 (150–300)
|
28
|
219.6 ± 28.2 (150–250)
|
26
|
n.s. b
|
|
Dialysis time (h)
|
4.0 ± 0.4 (3.0–5.0)
|
4.0 ± 0.4 (3.0–5.0)
|
28
|
4.0 ± 0.3 (3.0–5.0)
|
26
|
n.s. b
|
|
Effective surface area (m2)
|
1.7 ± 0.3 (1.3–2.1)
|
1.7 ± 0.3 (1.3–2.1)
|
28
|
1.7 ± 0.3 (1.4–2.1)
|
26
|
n.s. b
|
|
Dialysis membrane (PS/PES/PEPA)
|
(32/12/10)
|
(13/8/7)
|
28
|
(19/4/3)
|
26
|
n.s. a
|
|
Classification of dialyzer# (I·II/III/IV/V)
|
(0/6/26/22)
|
(0/1/16/11)
|
28
|
(0/5/10/11)
|
26
|
n.s. a
|
|
Dialysate (with acetate/without acetate)
|
(44/10)
|
(20/8)
|
28
|
(24/2)
|
26
|
p < 0.05 a
|
|
Medical history
|
|
Diabetes mellitus (Y/N)
|
(18/36)
|
(9/19)
|
28
|
(9/17)
|
26
|
n.s. a
|
|
Cerebrocardiovascular event (Y/N)
|
(12/42)
|
(7/21)
|
28
|
(5/21)
|
26
|
n.s. a
|
- Results are presented as the mean ± standard deviation, and the values in parentheses represent the minimum and maximum values
- #Classification of dialyzers in the Japanese reimbursement system
- aChi-square test
- bUnpaired t test
- cWelch’s test
